Elisa joined Portolano Cavallo in February 2017.

She has an extensive experience in regulatory and compliance matters with a particular focus, in the last years, on all legal matters regarding pharmaceuticals and medical devices and other areas of Life Sciences.

Her experience includes clinical trials, release to the market, promotion and marketing of pharmaceuticals and medical devices, etc. She has also gained significant experience in matters of protection of personal data in the context of clinical trials, with particular regard to the processing of genetic data, including through biobanks. In addition, she often advises on Life Sciences regulatory matters in the context of M&A transactions.

From 2010 until her arrival at Portolano Cavallo, Elisa worked at BonelliErede. Previously she worked in the Intellectual Property and Privacy Practice Group of Bird & Bird in Milan and before that with Studio Legale BLB and Nunziante Magrone.

From 2006 to 2010, she was Contract Professor in Public and Constitutional Law at the Università Commerciale Luigi Bocconi.

After being awarded a cum laude Law Degree by the Università Commerciale Luigi Bocconi in 2004, Elisa earned a post-graduate diploma at the Academy of European Law, European University Institute in Fiesole, in 2006, focusing on “New Technologies and Human Rights”, and completed her Ph.D. in Constitutional Law at the Università degli Studi di Milano in 2008, defending a dissertation on “Genetic Data and Privacy: A Comparative Perspective”. During her doctoral studies, Elisa conducted research at the King’s College London.

In 2020 she has been ranked by Legal500 as “Next Generation Lawyer” in the EMEA – Life Sciences guide. Furthermore, she has been included by Who’s Who Legal among the Life Sciences experts both in the WWL: Italy 2020 (“National Leader”) and the WWL: Life Sciences – Regulatory 2020 (“Global Leader”) guides.

She is the author of several publications in the field of biotechnology and scientific research, including the monograph “Genetic Data and Fundamental Rights. Comparative and European Law” (CEDAM, 2008), as well of numerous articles published on some of the field’s most prestigious journals, such as: “Publication of Clinical Trials Data: A New Approach to Transparency in the European Legislative Framework” (Medicine Access, October 11, 2017); “Genetic research and rights of the people involved: from an individual approach to an universal perspective” (Biotech Innovations and Fundamental Rights, Springer, 2011); “The exchange of genetic information in light of old rights and new challenges” (Genetic Data in Bio Law, CEDAM, 2011); “Italian Biobanks and the Need for Legislative Regulation” (in the Script-Ed, 2010); ”Shared genetic data: a new frontier for privacy” (European Comparative Public Law, 2008); “Principle of coexistence and GMO-free Regions: the end of the moratorium on genetically modified crops in Italy” (Constitutional Law, 2006).

She participates in the capacity of speaker in numerous conferences and seminars in the field of Life Sciences. Elisa is member of the AGENAS Experts and Collaborators’ Register in the Economic / Management – Juridical / Administrative and Management Training Area.

Foreign languages: English (speaking proficiency).

Elisa is a member of the Milan Bar association (2008004802).

---

From the Blog

The Italian Competition Authority Focuses Again on Social Media Advertising Practices

November 02, 2021 | Elisa Stefanini

Show more...

---

News

From Italy: Italian State Department apparently considers a new approach for prize contests with user generated content, by: Felix Hofer, Hofer Losch Torricelli

January 22, 2015

---

From Italy: Italian Regulator and SRO agree to dedicate special attention to commercial communication targeting minors, by: Felix Hofer, Hofer Losch Torricelli

January 21, 2015

---

From Italy: Felix Hofer to speak at AIPPI Seminar on Ambush Marketing on January 12, 2015 in Milan

January 19, 2015

Show more News...